ELIZABETH ARCENEAUX: Open Payments
NPI 1588143945 · HOUMA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 24 payments from 13 companies in 2025. Trend: 2023 $259 · 2024 $663 · 2025 $610
Food & beverage: $511Education: $99
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $145 |
| Janssen Biotech, Inc. | 3 | $86 |
| Lilly USA, LLC | 3 | $77 |
| Organon LLC | 2 | $55 |
| LEO Pharma Inc. | 3 | $54 |
| UCB, Inc. | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| GENZYME CORPORATION | 1 | $26 |
| Amgen Inc. | 1 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
Products named: DUPIXENT, TREMFYA, VTAMA, EBGLYSS, Bimzelx, ADBRY, Sotyktu, TALTZ.
Industry payments across LA — which companies pay providers there.
